1887

n African Journal of Psychiatry - Asenapine for long-term treatment of bipolar disorder : a double-blind 40-week extension study : product news

USD

 

Abstract

Asenapine is approved in the United States for acute treatment of manic or mixed episodes of bipolar I disorder with or without psychotic features. We report the results of long-term treatment with asenapine in patients with bipolar I disorder.

Loading

Article metrics loading...

/content/medjda2/15/6/EJC127130
2012-11-01
2016-12-09
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error